Dermatomyositis
Not recruitingStudy on the Safety and Efficacy of Empasiprubart for Adults with Dermatomyositis
Study on the Safety and Efficacy of Empasiprubart for Adults with Dermatomyositis
- Disease:Dermatomyositis
Greece- Participants:18–64 years · 65+ years










